The patients 18 years and older who were newly diagnosis and known to have Philadelphila-chromosome negative myeloproliferative neoplasms . Clinical characteristics and correlated molecular mutations of adult Philadelphila-chromosome negative myeloproliferative neoplasms
Conditions
Interventions
The patients 18 years and older who were newly diagnosis and known to have Philadelphila-chromosome negative myeloproliferative neoplasms by next-generating sequencing technique. Myeloproliferative
Other
The patients 18 years and older who were newly diagnosis and known to have Philadelphila-chromosome negative myeloproliferative neoplasms .
Sponsors
Siriraj Hospital Mahidol University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Newly diagnosis and known to have Philadelphila-chromosome negative myeloproliferative neoplasms . According to WHO 2016 diagnostic criteria 2.The patients 18 years and over 3 .The patients diagnosis and known to have Philadelphila-chromosome negative myeloproliferative neoplasms by next-generating sequencing technique. 4. The patients participate project by sign ICF.
Exclusion criteria
Exclusion criteria: Myeloproliferative neoplasms increases the number of detected Philadelphia chromosomes and / or the BCR-ABL mutation gene is detected.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Predictive factor for overall survival First clinic visit From medical record and case record form | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival 5 years From medical record (date of diagnosis, date of death, and date of last follow up) | — |
Countries
Thailand
Contacts
Public Contactweerapat Owattanapanich
Division of Hematology ,Faculty of Medicine Siriraj Hospital, Mahidol University .
Outcome results
None listed